Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behçet's disease | Zendy

Joanne Malkin | Zendy; Anna Shrimpton | Zendy; Martin Wiselka | Zendy; Michael R. Barer | Zendy; M Duddridge | Zendy; Nelun Perera | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behçet's disease

Author(s) -

Joanne Malkin,

Anna Shrimpton,

Martin Wiselka,

Michael R. Barer,

M Duddridge,

Nelun Perera

Publication year - 2009

Publication title -

journal of medical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.91

H-Index - 117

eISSN - 1473-5644

pISSN - 0022-2615

DOI - 10.1099/jmm.0.006809-0

Subject(s) - mycobacterium kansasii , medicine , bursitis , infliximab , immunosuppression , dermatology , olecranon , immunology , surgery , mycobacterium , tumor necrosis factor alpha , pathology , elbow , tuberculosis

We present a case of Mycobacterium kansasii olecranon bursitis in a woman with known immunosuppression secondary to the treatment received for her Behçet's disease. We found only one other case report of olecranon bursitis caused by M. kansasii in the literature, which, unlike our case, presented in an immunocompetent adult following trauma. This case extends the range of opportunistic mycobacterial infections that are associated with anti-tumour necrosis factor therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research